Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Co-opting templated aggregation to degrade pathogenic tau assemblies and improve motor function
Lauren V. C. Miller, Guido Papa, Marina Vaysburd, et al.
Cell (2024)
Open Access | Times Cited: 14

Showing 14 citing articles:

Proteolytic therapeutic modalities for amyloidoses: Insights into immunotherapy, PROTAC, and photo-oxygenation
Mai Kuriyama, C Wang, Takahide Nagase, et al.
Neurotherapeutics (2025), pp. e00548-e00548
Open Access | Times Cited: 1
Tau degradation in Alzheimer's disease: Mechanisms and therapeutic opportunities
Lisha Wang, Sooram Banesh, Rajnish Kumar, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 3
Open Access | Times Cited: 1
Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics
Lisha Ou, Mekedlawit Setegne, Jeandele Elliot, et al.
Chemical Reviews (2025)
Closed Access
Sensitive detection and propagation of brain-derived tau assemblies in HEK293 based wild-type tau seeding assays
Melissa Huang, William A. McEwan
Journal of Biological Chemistry (2025), pp. 108245-108245
Open Access
Genetically-encoded targeted protein degradation technology to remove endogenous condensation-prone proteins and improve crop performance
Ming Luo, Sitao Zhu, Hua Dang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Cerium-doped Prussian blue biomimetic nanozyme as an amplified pyroptosis inhibitor mitigate Aβ oligomer-induced neurotoxicity in Alzheimer’s disease
Jing Ma, Yu Tian, Chengzhong Du, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Targeting neurodegenerative disease-associated protein aggregation with proximity-inducing modalities
Ruixin Ge, Miao Chen, Qingchao Li, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
Distinct factors drive the progression of tau pathology in Alzheimer's disease
Yifan Luo, Honglu Yu, Keqiang Ye
Fundamental Research (2025)
Open Access
A No-Brainer! The Therapeutic Potential of TRIM Proteins in Viral and Central Nervous System Diseases
Adam Hage, Marianne Janes, Sonja M. Best
Viruses (2025) Vol. 17, Iss. 4, pp. 562-562
Open Access
Targeted Protein Degradation: From Basic Science to Therapeutic Applications
R Zhu, Xiaoyu Tang, Heng Zhang
ACS Chemical Biology (2025)
Closed Access
Pathological Involvement of Protein Phase Separation and Aggregation in Neurodegenerative Diseases
Y. Wu, Biao Ma, Chang Yu Liu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10187-10187
Open Access | Times Cited: 3
Targeted protein degradation with bifunctional molecules as a novel therapeutic modality for Alzheimer's disease & beyond
Carl Alexander Sandhof, Helen C. Murray, M. Catarina Silva, et al.
Neurotherapeutics (2024), pp. e00499-e00499
Closed Access | Times Cited: 2
Targeted degradation of endogenous condensation-prone proteins improves crop performance
Ming Luo, Qing Wen, Sitao Zhu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Downregulation of astrocytic C3 production alleviates neuronal mitochondrial dysfunction in tauopathy models
Chenxu Lei, Bocheng Zhang, Junji Yamaguchi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1

Scroll to top